PMID- 20934770
OWN - NLM
STAT- MEDLINE
DCOM- 20110321
LR  - 20220410
IS  - 1872-8227 (Electronic)
IS  - 0168-8227 (Linking)
VI  - 90
IP  - 3
DP  - 2010 Dec
TI  - Evidence on the applicability of the ATPIII, IDF and CDS metabolic syndrome 
      diagnostic criteria to identify CVD and T2DM in the Chinese population from a 
      6.3-year cohort study in mid-eastern China.
PG  - 319-25
LID - 10.1016/j.diabres.2010.09.001 [doi]
AB  - AIMS: This study evaluates the effectiveness of three metabolic syndrome (MS) 
      criteria in identifying cardiovascular disease (CVD) and type 2 diabetes mellitus 
      (T2DM) in the Chinese population. METHODS: 3598 subjects were recruited from a 
      cohort study on Prevention of Multiple Metabolic disorders and MS in Jiangsu of 
      China (PMMJS), followed at 6.3 years. MS was diagnosed using criteria of the 
      National Cholesterol Education Program's Adult Treatment Panel III (ATPIII), the 
      International Diabetes Federation (IDF) and Chinese Diabetes Society (CDS). Cox 
      regression model was used to analysis the association between MS and onset of CVD 
      and T2DM. Receiver operating characteristic (ROC) curve, sensitivity and 
      specificity were also used to test the ability of three MS criteria to identify 
      CVD or T2DM. RESULTS: Among three criteria, CDS has the highest specificity but 
      lowest sensitivity. Using the CDS criterion, over 50 percent of patients would be 
      misdiagnosed. ATPIII criterion has the shortest distance in ROC curve, lowest 
      false positive rate and false negative rate for identifying CVD and T2DM. 
      ATPIII+/IDF+ has lower ability to predict CVD than ATPIII+/IDF-. ATPIII+/IDF+ and 
      ATPIII+/IDF- has similar ability to predict T2DM. CONCLUSIONS: The ATPIII-MS 
      criterion has the highest ability to predict CVD and T2DM. ATPIII is the best MS 
      criterion for the Chinese population.
CI  - Copyright (c) 2010 Elsevier Ireland Ltd. All rights reserved.
FAU - Zhou, Hui
AU  - Zhou H
AD  - Center for Disease Control and Prevention of Suzhou Industry Park, SuZhou, 
      JiangSu, China.
FAU - Guo, Zhi-rong
AU  - Guo ZR
FAU - Yu, Lu-gang
AU  - Yu LG
FAU - Hu, Xiao-shu
AU  - Hu XS
FAU - Xu, Bao-hui
AU  - Xu BH
FAU - Liu, Hai-bo
AU  - Liu HB
FAU - Wu, Ming
AU  - Wu M
FAU - Zhou, Zheng-yuan
AU  - Zhou ZY
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20101008
PL  - Ireland
TA  - Diabetes Res Clin Pract
JT  - Diabetes research and clinical practice
JID - 8508335
SB  - IM
MH  - Adult
MH  - Aged
MH  - Cardiovascular Diseases/*diagnosis
MH  - China/epidemiology
MH  - Cohort Studies
MH  - Diabetes Mellitus, Type 2/*diagnosis/epidemiology
MH  - False Negative Reactions
MH  - False Positive Reactions
MH  - Female
MH  - Humans
MH  - Male
MH  - Metabolic Syndrome/*diagnosis/epidemiology
MH  - Middle Aged
MH  - Prevalence
MH  - ROC Curve
MH  - Risk Factors
MH  - Sensitivity and Specificity
EDAT- 2010/10/12 06:00
MHDA- 2011/03/22 06:00
CRDT- 2010/10/12 06:00
PHST- 2009/10/21 00:00 [received]
PHST- 2010/08/22 00:00 [revised]
PHST- 2010/09/02 00:00 [accepted]
PHST- 2010/10/12 06:00 [entrez]
PHST- 2010/10/12 06:00 [pubmed]
PHST- 2011/03/22 06:00 [medline]
AID - S0168-8227(10)00446-8 [pii]
AID - 10.1016/j.diabres.2010.09.001 [doi]
PST - ppublish
SO  - Diabetes Res Clin Pract. 2010 Dec;90(3):319-25. doi: 
      10.1016/j.diabres.2010.09.001. Epub 2010 Oct 8.